HUMIRA PEN for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 46 adverse event reports in the FDA FAERS database where HUMIRA PEN was used for Psoriasis.
Most Reported Side Effects for HUMIRA PEN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 38 | 14.7% | 0 | 3 |
| Arthralgia | 28 | 10.9% | 0 | 5 |
| Drug ineffective | 28 | 10.9% | 0 | 5 |
| Pain | 19 | 7.4% | 0 | 6 |
| Headache | 18 | 7.0% | 0 | 2 |
| Nasopharyngitis | 18 | 7.0% | 0 | 2 |
| Psoriasis | 16 | 6.2% | 0 | 1 |
| Fatigue | 15 | 5.8% | 1 | 3 |
| Incorrect dose administered | 15 | 5.8% | 0 | 4 |
| Nausea | 15 | 5.8% | 0 | 5 |
| Cough | 14 | 5.4% | 0 | 3 |
| Diarrhoea | 14 | 5.4% | 0 | 8 |
| Abdominal pain | 13 | 5.0% | 0 | 7 |
| Crohn's disease | 13 | 5.0% | 0 | 7 |
| Injection site bruising | 13 | 5.0% | 0 | 0 |
Other Indications for HUMIRA PEN
Rheumatoid arthritis (92)
Crohn's disease (70)
Psoriatic arthropathy (30)
Ankylosing spondylitis (10)
Colitis ulcerative (9)
Product used for unknown indication (5)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)